Kevin Pohlman - Patterson Companies Interim President - Patterson Animal Health

PDCO Stock  USD 25.97  0.06  0.23%   

President

Mr. Kevin Pohlman was appointed as Interim President of Patterson Animal Health, subsidiary of the Company, effective July 01, 2017. Mr. Pohlman joined the Animal Health business in August 2001 and currently serves as Vice President of Sales and Marketing. Prior to assuming that role, Mr. Pohlman was President of Corporationrationrate Sales and Marketing for Animal Health. Beginning in 2001, Mr. Pohlman held a variety of leadership roles at Lextron, where he most recently served as Vice President of Dealer Sales with oversight of the Marketing department until June 2011. Mr. Pohlman began his career with Pohlman Bros. Supply, a familyowned dealer and distributor of dairy equipment, animal health supplies and food plant supplies in Ohio. since 2017.
Age 61
Tenure 7 years
Address 1031 Mendota Heights Road, Saint Paul, MN, United States, 55120
Phone651 686 1600
Webhttps://www.pattersoncompanies.com

Patterson Companies Management Efficiency

The company has return on total asset (ROA) of 0.0596 % which means that it generated a profit of $0.0596 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1865 %, meaning that it created $0.1865 on every $100 dollars invested by stockholders. Patterson Companies' management efficiency ratios could be used to measure how well Patterson Companies manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Patterson Companies' Return On Tangible Assets are very stable compared to the past year. As of the 25th of April 2024, Return On Assets is likely to grow to 0.1, while Return On Capital Employed is likely to drop 0.09. At this time, Patterson Companies' Fixed Asset Turnover is very stable compared to the past year. As of the 25th of April 2024, Return On Assets is likely to grow to 0.1, while Total Assets are likely to drop about 1.9 B.
The company currently holds 628 M in liabilities with Debt to Equity (D/E) ratio of 0.7, which is about average as compared to similar companies. Patterson Companies has a current ratio of 1.6, which is within standard range for the sector. Debt can assist Patterson Companies until it has trouble settling it off, either with new capital or with free cash flow. So, Patterson Companies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Patterson Companies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Patterson to invest in growth at high rates of return. When we think about Patterson Companies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Bethanie SteinHumana Inc
N/A
Brian LeClaireHumana Inc
57
Regina NetheryHumana Inc
N/A
Elizabeth BierbowerHumana Inc
59
Christopher TodoroffHumana Inc
54
Paul MarchettiElevance Health
N/A
George IIHumana Inc
55
Scott TowersElevance Health
N/A
Christopher KayHumana Inc
50
Beth ChesmhaElevance Health
55
Alan WheatleyHumana Inc
51
Thomas ListonHumana Inc
51
Susan DiamondHumana Inc
50
Tim McClainHumana Inc
64
MD MBAHumana Inc
50
William FlemingHumana Inc
53
David DintenfassHumana Inc
N/A
John IIIHumana Inc
N/A
Heidi MargulisHumana Inc
63
Cynthia ZipperleHumana Inc
58
Roy BeveridgeHumana Inc
59
Patterson Companies, Inc. engages in distribution of dental and animal health products in the United States, the United Kingdom, and Canada. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota. Patterson Companies operates under Medical Distribution classification in the United States and is traded on NASDAQ Exchange. It employs 7700 people. Patterson Companies (PDCO) is traded on NASDAQ Exchange in USA. It is located in 1031 Mendota Heights Road, Saint Paul, MN, United States, 55120 and employs 7,600 people. Patterson Companies is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Patterson Companies Leadership Team

Elected by the shareholders, the Patterson Companies' board of directors comprises two types of representatives: Patterson Companies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Patterson. The board's role is to monitor Patterson Companies' management team and ensure that shareholders' interests are well served. Patterson Companies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Patterson Companies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Kevin Pohlman, Interim President - Patterson Animal Health
Dennis Goedken, Interim CFO, Treasurer
Kevin Barry, Interim Officer
Alex Blanco, Director
Tim Rogan, Pres Dental
Sean Muniz, Vice President - Operations
Neil Schrimsher, Director
John Wright, Vice President of Investor Relations
Paul Guggenheim, President of Patterson Dental Supply, Inc.
Ellen Rudnick, Independent Director
Shivani Kaul, Chief Officer
Donald Zurbay, President CEO
Samantha Bergeson, Chief Officer
Sarena Lin, Director
Timothy Rogan, President Dental
Les Vinney, Independent Director
Les Korsh, Vice President General Counsel, Secretary
Andrea Frohning, Chief Officer
Francis Malecha, Director
Robert Frenzel, Director
Jerome Thygesen, Vice President - Human Resources
Douglas Jones, President - Companion Animal Group
James Wiltz, Director
George Henriques, President of Patterson Veterinary Supply, Inc.
David Misiak, President - Patterson Dental North America
Kelly Baker, Chief Human Resource Officer
Mark Walchirk, President CEO, Director
Ann Gugino, CFO, Executive VP and Treasurer
Jody Feragen, Independent Director
Ranell Hamm, CIO
Dave Lardy, Chief Officer
John Buck, Independent Director
Scott Anderson, Chairman, CEO and Pres
John Adent, CEO - Patterson Animal Health

Patterson Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Patterson Companies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Patterson Companies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Patterson Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Patterson Companies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Patterson Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Patterson Companies Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Patterson Companies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Patterson Stock, please use our How to Invest in Patterson Companies guide.
Note that the Patterson Companies information on this page should be used as a complementary analysis to other Patterson Companies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Patterson Stock analysis

When running Patterson Companies' price analysis, check to measure Patterson Companies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Patterson Companies is operating at the current time. Most of Patterson Companies' value examination focuses on studying past and present price action to predict the probability of Patterson Companies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Patterson Companies' price. Additionally, you may evaluate how the addition of Patterson Companies to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Commodity Directory
Find actively traded commodities issued by global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is Patterson Companies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Patterson Companies. If investors know Patterson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Patterson Companies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Dividend Share
1.04
Earnings Share
2.03
Revenue Per Share
69.215
Quarterly Revenue Growth
0.01
The market value of Patterson Companies is measured differently than its book value, which is the value of Patterson that is recorded on the company's balance sheet. Investors also form their own opinion of Patterson Companies' value that differs from its market value or its book value, called intrinsic value, which is Patterson Companies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Patterson Companies' market value can be influenced by many factors that don't directly affect Patterson Companies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Patterson Companies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Patterson Companies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Patterson Companies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.